Common questions about Дентинокс (FAQ)
Q: Is Дентинокс a painkiller?
The official product information classifies Дентинокс as a local anesthetic and anti-inflammatory combination. Its general purpose is the symptomatic mitigation, or relief, of pain and irritation in the oral mucosa. Therefore, it works locally to numb the area causing discomfort rather than systemically relieving pain like a tablet.
Q: Is it normal for me to feel a slight tingling sensation after applying Дентинокс?
The active component functions as a local anesthetic that temporarily abolishes sensory transmission, which may result in temporary sensations at the application site. Local irritation is listed as a potential effect in official documents, though its exact frequency is not known. If any sensation is severe or concerning, regulatory documentation advises seeking medical attention.
Q: What are the most common concerns or negative experiences people report about Дентинокс?
Official documents detail the risk of hypersensitivity reactions to ingredients like chamomile or localized effects such as temporary redness or irritation. The most serious safety warning issued by regulatory authorities relates to the potential for adverse systemic effects associated with the excessive absorption of the lidocaine component, which applies to the entire class of topical oral local anesthetics.
Q: Do any official sources suggest that Дентинокс is ineffective?
Studies that examined the use of Дентинокс describe measurements of changes in patient discomfort during use. However, regulatory documents indicate that the certainty of the evidence remains low and sample sizes were modest in controlled trials. The research base provides context, but the findings may not fully represent the response of a larger, diverse population.
Q: If I accidentally swallow a small amount of Дентинокс, what should I do?
Official guidance addresses accidental ingestion by focusing on safety limits. If a dose is swallowed, regulatory instructions require the next dose to still adhere to the minimum 3-hour interval between applications. This constraint is intended to prevent the total administered amount from exceeding the 24-hour safety limit.
Q: Can people with sensitive skin or allergies to other medications use Дентинокс?
The preparation is contraindicated, or forbidden, for use by individuals with a known hypersensitivity to its specific active ingredients, such as lidocaine and chamomile, or to certain inactive ingredients like parahydroxybenzoates. Special caution is also required when applying the gel to an area with extensive mucosal injuries due to the potential for increased absorption.
Q: What are the typical non-serious side effects associated with Дентинокс?
Non-serious local reactions listed in the regulatory documents include local irritation and temporary redness of the oral mucosa at the site of application. It should be noted that the frequency of these particular effects is officially classified as not known in the regulatory materials.
Q: Does Дентинокс have an expiry date, and does it become less effective over time?
Regulatory documents state that the medicine has an official shelf life of one year after the container is first opened. To ensure product stability and safety, official protocols require consulting a pharmacist for guidance on proper disposal of expired or unused medicine. Product stability and effectiveness beyond the stated shelf life are not established in official information.
Q: Can I use Дентинокс if I am taking other topical medications in the same area?
The official restrictions specifically mandate that the gel must not be used simultaneously with any other product that contains the same active ingredient, lidocaine. The regulatory information does not explicitly specify restrictions regarding other topical medications that do not contain lidocaine.
Q: Why is the application amount for Дентинокс described as 'a small quantity'?
Regulatory documents specify a small, pea-sized quantity as the standard application amount. This measure is intended to minimize the total dose administered in order to reduce the potential for increased systemic absorption of the active ingredient lidocaine. Excessive absorption of lidocaine has been associated with serious adverse systemic effects.
Q: Do the ingredients in Дентинокс absorb into the bloodstream?
Regulatory documents refer to the potential for increased systemic absorption of the lidocaine component, particularly when applied to areas with extensive mucosal injuries. The systemic safety warning itself indicates that the ingredient can potentially enter the bloodstream, which is why strict dosing limits are required.
Q: Has there been any public safety communication (e.g., recalls, alerts) regarding Дентинокс?
Regulatory authorities, including the FDA, have issued specific safety warnings concerning the use of the class of topical oral local anesthetics, such as lidocaine, in infants and young children for teething pain. These communications cite the potential for serious adverse systemic effects if the product is misused or over-applied.
Q: What is the main difference between Дентинокс and other products used for the same purpose?
The official description highlights that Дентинокс is a multicomponent stomatological preparation formulated as a hybrid. It combines a clinically recognized synthetic local anesthetic (lidocaine) with a standardized botanical extract (chamomile) that contributes anti-inflammatory properties. This combination results in the complementary action of numbing and soothing.
Q: Does Дентинокс contain any substances that are regulated or controlled?
The active ingredient Lidocaine HCl belongs to the pharmacological class of local anesthetics, which is a regulated class of medicines. Depending on the country and concentration, the product's market status may be controlled by health authorities, resulting in a classification such as Over-The-Counter ( OTC) or Pharmacy Only.
Q: How quickly should I expect Дентинокс to start working?
The general purpose of the preparation is to provide rapid, localized symptomatic mitigation of pain. The mechanism of the lidocaine component is to temporarily abolish sensory transmission at the nerve endings at the site of application, suggesting a quick onset of local effect.
Q: How long does the effect of Дентинокс usually last?
While the exact duration of action is not specified in the regulatory text, official dosing guidelines permit the dose to be repeated if necessary after a minimum of three hours. This minimum interval is set to ensure that the total administered amount does not exceed the maximum 24-hour limit.
Q: Can Дентинокс be used by people with general medical conditions (e.g., high blood pressure)?
The product is licensed and formulated exclusively for the pediatric population from five months of age. Its use is not established or applicable for adults, including those with pre-existing conditions like high blood pressure or diabetes, and the regulatory documentation focuses on warnings relevant to the pediatric target group.
Q: Does using Дентинокс make me drowsy or affect my ability to drive?
Дентинокс is a topical gel for localized use and is not generally intended to have systemic effects like drowsiness. However, serious adverse systemic effects that affect the central nervous system ( CNS) are a documented potential risk associated with the excessive absorption of the lidocaine component, which is why strict adherence to the application limits is required.
Q: Is Дентинокс available without a prescription?
The product is generally classified by regulatory bodies as a non-prescription medicine. It is typically designated as an Over-The-Counter ( OTC) or Pharmacy Only medicine based on its components and intended use.
Q: Do official documents specify if Дентинокс can be used during pregnancy or breastfeeding?
The preparation is licensed and formulated exclusively for the pediatric population. Consequently, its use is not established or applicable for adults, including those who are pregnant or breastfeeding, and the official documents do not provide safety data for these populations.
Q: What does 'contraindication' mean in the context of using Дентинокс?
In the context of official drug labeling, a contraindication means that the use of the medicine is absolutely forbidden because the potential risk outweighs any benefit. For Дентинокс, this applies to specific conditions like a known hypersensitivity to the ingredients or hereditary fructose intolerance.
Q: Is it possible to become dependent on Дентинокс?
The preparation is authorized for short-term use only, not exceeding seven consecutive days without medical consultation. Official regulatory documents do not mention or specify a risk of dependence or addiction associated with its use.
Q: Is the packaging of Дентинокс child-resistant?
While the specific physical standard of the packaging is not detailed in the core regulatory documents, the official label mandates that the gel must be stored strictly out of the sight and reach of children. The emphasis is placed on parental control and safe storage to ensure child safety.
Q: What should I do if a side effect of Дентинокс feels unusual or severe?
The regulatory label advises that if you observe signs of serious systemic adverse effects or severe hypersensitivity reactions, regulatory documents advise immediately stopping the use of the product. You are advised to seek urgent medical attention in such circumstances.
Q: Can people with a history of liver or kidney issues use Дентинокс?
The preparation is licensed for localized use in children, and the regulatory information does not explicitly list hepatic or renal impairment as a contraindication or special warning. The key warnings focus on local and allergic risks, as well as the risk of systemic absorption of lidocaine.
Q: What distinguishes the active ingredients of Дентинокс from its inactive ones?
The active ingredients, such as Lidocaine HCl and Chamomile extract, are the components that produce the intended pharmacological effect of numbing and soothing. Inactive ingredients are substances added for formulation, stability, or to aid application, but they do not produce the therapeutic effect.
Q: Does the use of Дентинокс mask symptoms of a more serious underlying issue?
The general purpose of the preparation is to provide symptomatic mitigation of discomfort. Regulatory guidelines mandate that use is strictly short-term (maximum 7 days) and should not continue without medical consultation if symptoms persist, reinforcing that it is intended for temporary relief.
